Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference

ErascaJan 31 00:00 ET

Erasca (NASDAQ:ERAS) Is In A Good Position To Deliver On Growth Plans

Yahoo FinanceJan 21 05:55 ET

Down -27.17% in 4 Weeks, Here's Why Erasca (ERAS) Looks Ripe for a Turnaround

Yahoo FinanceJan 20 09:35 ET

BofA Securities Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsJan 15 05:32 ET · Ratings

BofA Securities Upgrades Erasca(ERAS.US) to Buy Rating, Announces Target Price $5

Moomoo NewsJan 7 07:36 ET · Ratings

Erasca Upgraded to Buy From Neutral at BofA

TipRanksJan 7 07:16 ET · Ratings